Chris McNulty
Papers
1
Total Citations
152
H-Index
1
About
Chris McNulty is a pioneering figure in solid-state chemistry and pharmaceutical materials science, best known for advancing high-throughput crystallization methodologies to discover and characterize polymorphs. His seminal 2002 paper on acetaminophen, cited over 150 times, introduced the CrystalMax platform—an integrated system of design software, robotic handling, and microanalytics capable of running thousands of experiments. This work led to the identification and structural determination of Form III of acetaminophen, a breakthrough that demonstrated how automated, iterative polymorphism studies could uncover elusive crystal forms critical to drug development and intellectual property. McNulty’s contributions have had a lasting impact on the field, enabling researchers to systematically explore solid-form landscapes with unprecedented speed and reliability. His work is widely recognized for bridging high-throughput experimentation with fundamental structural chemistry, influencing both academic research and industrial pharmaceutical development.
Research Focus
Key Achievements
Top Papers
- 1